Want to join the conversation?
$REGN 2Q15 Call: Phase 2 study of Dupilumab in eosinophilic esophagitis is ongoing and currently enrolling patients. NURSERY-PreTerm is enrolling patients in the Southern Hemisphere where the RSV season is from May through October; a second Phase 3 trial in this indication is planned for later this year in Northern Hemisphere.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)